EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Efficacy and safety of bivalirudin and heparin with or without glycoprotein IIb/IIIa inhibitors in patients of acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and network meta-analysis

Maryam Adnan, Hamza Naveed, Mohammad Hamza, Muhammad Irtaza Hussain Bakhtiari, Mueed Chaudhry, Muhammad Naqi, Munis Mahboob, Jawad Basit, Wael Al-Jaroudi, Timir K Paul, M Chadi Alraies

Archives of Medical Science – Atherosclerotic Diseases · 25.06.2026 · 11 (1) · 87-101

DOI: 10.5114/amsad/220588 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 25.06.2026. Verfasst von Maryam Adnan und 10 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent clinical trials have revealed that bivalirudin has comparable efficacy to heparin. In this network meta-analysis, we aimed to compare the efficacy and safety of bivalirudin and heparin administered as monotherapy or with glycoprotein IIb/IIIa inhibitors, in patients of acute coronary syndromes undergoing percutaneous coronary intervention (PCI). Material and methods We performed a systematic search of PubMed and Embase to identify studies with acute coronary syndrome patients > 18 years, who underwent PCI, and were treated with bivalirudin or heparin either as monotherapy or with glycoprotein IIb/IIIa inhibitors. Outcomes were major bleeding, major adverse cardiovascular events (MACE), all-cause mortality, reinfarction, stent thrombosis and cardiovascular death. Pooled relative risks (RR) were calculated using the net-meta module with/and random effects model with a 95% confidence interval (CI) for statistical significance. Higgins I2 statistic was used to assess heterogeneity.

Results

A total of 23 randomized controlled trials comprising 72,628 patients were included. Bivalirudin monotherapy compared to heparin monotherapy demonstrated no significant difference in risk of bleeding (RR = 0.83, 95% CI: 0.64–1.08, p = 0.17), MACE (RR = 0.99, 95% CI: 0.93–1.05, p = 0.72) and other outcomes. Bivalirudin combined with GP IIb/IIIa inhibitors had an increased risk of stent thrombosis compared with heparin monotherapy (RR = 3.62, 95% CI: 1.002–13.14). In major bleeding, heparin with GP IIb/IIIa inhibitors had a statistically significant RR of 1.454 (95% CI: 1.006–2.1009, p = 0.045).

Conclusions

Bivalirudin and heparin have similar efficacy and safety profiles in patients undergoing PCI for ACS. The choice of the anticoagulant should be individualized based on patient and procedural characteristics.

Zitieren

APA

Adnan, M., Naveed, H., Hamza, M., Bakhtiari, M. I. H., Chaudhry, M., Naqi, M., Mahboob, M., Basit, J., Al-Jaroudi, W., Paul, T. K., & Alraies, M. C. (2026). Efficacy and safety of bivalirudin and heparin with or without glycoprotein IIb/IIIa inhibitors in patients of acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and network meta-analysis. Archives of Medical Science – Atherosclerotic Diseases, 11(1), 87-101. https://doi.org/10.5114/amsad/220588

Vancouver

Adnan M, Naveed H, Hamza M, Bakhtiari MIH, Chaudhry M, Naqi M, et al. Efficacy and safety of bivalirudin and heparin with or without glycoprotein IIb/IIIa inhibitors in patients of acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and network meta-analysis. Archives of Medical Science – Atherosclerotic Diseases. 2026;11(1):87-101. doi:10.5114/amsad/220588

BibTeX
@article{Adnan2026,
  author = {Adnan, Maryam and Naveed, Hamza and Hamza, Mohammad and Bakhtiari, Muhammad Irtaza Hussain and Chaudhry, Mueed and Naqi, Muhammad and Mahboob, Munis and Basit, Jawad and Al-Jaroudi, Wael and Paul, Timir K and Alraies, M Chadi},
  title = {Efficacy and safety of bivalirudin and heparin with or without glycoprotein IIb/IIIa inhibitors in patients of acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and network meta-analysis},
  journal = {Archives of Medical Science – Atherosclerotic Diseases},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {87--101},
  doi = {10.5114/amsad/220588}
}
Kostenlos starten →